SEC
Fundamental Analysis
11 matches · 10756 cached companies
| Company | Fundamental | Momentum | Acceleration | Confidence | Revenue Growth | ROIC | FCF Growth | Op Margin Delta | Share Growth | Dividend Yield | Dividend Years | Payout Ratio | P/E | Signals |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| URGNUroGen Pharma Ltd. | 64.9 | n/a | n/a | 68 | +85.13% | n/a | n/a | n/a | n/a | 0% | 0 | n/a | n/a | Gross margin expansion3 warnings |
| AXGNAxogen, Inc. | 50.9 | 65.8 | 65.8 | 77 | +32.94% | -0.8% | n/a | +27.88% | +18% | 0% | 0 | n/a | n/a | Operating leverage, Net debt reduction1 warning |
| OGENORAGENICS INC | 53.2 | n/a | n/a | 73 | +63.05% | n/a | n/a | n/a | n/a | 0% | 0 | n/a | n/a | Net debt reduction1 warning |
| NEONEOGENOMICS INC | 50.3 | n/a | n/a | 63 | +8.75% | n/a | n/a | n/a | n/a | 0% | 0 | n/a | n/a | n/a |
| MGNXMACROGENICS INC | 39.1 | 100 | 60 | 76 | -7.29% | -1,404.69% | n/a | +187.58% | +1% | 0% | 0 | n/a | n/a | Operating leverage, Net debt reduction3 warnings |
| ORGOOrganogenesis Holdings Inc. | 35.9 | 0 | 0 | 82 | -24.71% | -75.09% | n/a | -38.45% | +1.88% | 0% | 0 | n/a | n/a | Gross margin expansion3 warnings |
| BIIBBIOGEN INC. | 37.5 | n/a | n/a | 79 | +3.46% | n/a | n/a | n/a | +1.57% | 0% | 0 | n/a | 19.64x | Net debt reduction |
| INGNInogen Inc | 32.5 | 75 | 77.5 | 83 | +11.84% | -29.47% | n/a | -11.77% | +7.47% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion2 warnings |
| TGENTECOGEN INC. | 30.2 | 0 | 0 | 83 | +12.01% | -74.59% | n/a | -12.45% | +20.22% | 0% | 0 | n/a | n/a | Net debt reduction4 warnings |
| NEOGNEOGEN CORP | 19.6 | 3.8 | 18.4 | 92 | -7.07% | -0.5% | n/a | -11.22% | +0.39% | 0% | 0 | n/a | n/a | Net debt reduction3 warnings |
| CCOICOGENT COMMUNICATIONS HOLDINGS, INC. | 24.4 | n/a | n/a | 62 | +7.95% | n/a | n/a | n/a | n/a | 0.95% | 15 | n/a | n/a | n/a |
1-11 of 11